A New Kind of Pharmacist
Linda von Wartburg |
Feb 20, 2011 |
Ross Valley Pharmacy, tucked away inside a larger building of clinics, is not a big place, but it's very very busy. Its owner, pharmacist Paul Lofholm, has a vision of the pharmacist's role that goes far beyond simply putting pills in bottles. He sees pharmacists as integral members of the healthcare team who can fill the gaps in patients' education about their conditions and their medications.
Need Medicine and Have No Insurance for Your Diabetes?
Feb 14, 2011 |
Nearly one in six people in the United States has no health insurance. If you have diabetes, that's a very tough position to be in. There are, however, resources that can cut the costs that you have been paying out of pocket for medicines and supplies.
Grapefruit and Metformin May Have Ill Effects on the Body's pH Levels
Patrick Totty |
Oct 26, 2009 |
A South African university pharmacologist has found that simultaneous consumption of metformin and grapefruit juice raises lactic acid to dangerous levels in rats (and conceivably in people) with type 2 diabetes. Too much acid in the blood can cause low pH levels that interfere with the body's metabolic functions. Conceivably, says Dr. Peter Owira, a pharmacologist at the University of KawZulu-Natal, such low levels could be fatal.
Doctors Urged to Stop Accepting Bri- —Oops, Make That Gifts—From Big Pharma
Linda von Wartburg |
Jun 12, 2009 |
Drug companies spend billions of dollars on research, and it's obvious that they spend more billions on advertising. Well, according to the New York Times, they spend the most billions on giving nice things to doctors: pens, samples, banquets, trips, and educational opportunities among them. For doctors, in fact, there is a free lunch: Pharma companies spend as much as a billion a year just on lunches for doctors. And over 90 percent of doctors have accepted at least some of this largesse from the industry.
Insulin For Type 2 Diabetes: Who, When, And Why?
Robert Tanenberg, MD, FACP |
Mar 20, 2009 |
Physicians who treat people with type 2 diabetes face difficult choices when selecting the best medical therapy for each patient. The decision process is further complicated by the fact that because type 2 diabetes is a progressive disease, therapeutic agents that were initially successful may fail five or ten years later.
Diabetes Health Medical Disclaimer
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.